Syncona Share News (SYNC)
SYNC Share
SYNC Share
SYNC Share
SYNC Share
SYNC
SYNC Share
SYNC Level 2
SYNC Live
SYNC Broker
SYNC Directors
SYNC Financial
SYNC
SYNC Short
SYNC
Last checked at -
To deliver superior long-term capital appreciation from investments in life science businesses, leading long-only and alternative investment funds and managed accounts across multiple asset classes.
Find out More
(Sharecast News) - Healthcare investment company Syncona reported net assets of £1.37bn in its interim results on Thursday, down from £1.46bn at the end of the last financial year.
Read more
(Alliance News) - Syncona Ltd said Tuesday it has made investments totalling GBP83.1 million in two companies in separate Series B financing rounds.The FTSE 250 healthcare-focused firm made
Read more(Sharecast News) - Syncona on Tuesday confirmed investments of £48.0m in retinal gene therapy group Gyroscope Therapeutic and £35.1m in cancer immunotherapies developer Achilles Therapeutics.
Read more(Correcting that the net asset value per share as at March 31 was 216.8p, meaning NAV decreased over the course of the quarter.)(Alliance News) - Healthcare investor Syncona Ltd said its in
Read more(Alliance News) - Healthcare investor Syncona Ltd said Thursday its net asset value rose in the first quarter of its financial year, despite a drop in the value of its portfolio due to a declining
Read moreMonday 12 August ClarksonHalf Year ResultsSynconaQuarterly 13 Year Year
Read more(Alliance News) - Healthcare-focused investment firm Syncona Ltd said Monday that portfolio company Freeline Therapeutics has published 12-month data from an ongoing trial in haemophilia B, and a
Read more(Alliance News) - Investment firm Syncona Ltd on Thursday said it has agreed to sell its portfolio company Blue Earth Diagnostics to Bracco Imaging for USD450 million plus closing adjustment at in
Read more(Alliance News) - Life sciences investor Syncona Ltd on Thursday reported a "strong" annual performance, with core life sciences firms doing well, while it is also to halt is paying a to
Read moreFriday 7 June Seneca Global Income & Growth TrustFull Year ResultsMonday 10 traffic 11
Read moreLONDON (Alliance News) - Healthcare company Syncona Ltd on Tuesday said Melanie Gee will take over the chair of its board from Jeremy Tigue over the coming months in preparation for Tigue's at
Read moreLONDON (Alliance News) - Healthcare company Syncona Ltd said Monday it has established a new cell therapy company, Quell Therapeutics, with GBP35 million financing commitment.Syncona has -
Read more(Sharecast News) - Syncona confirmed on Monday that it has founded a new cell-therapy treatment company, pitching in with £34.0m to fund the new venture in exchange for a 69.3% stake.
Read moreLONDON (Alliance News) - The following stocks are the leading risers and fallers within the main London indices on Tuesday.----------FTSE 100 - up 1.8%. The telecommunications firm said it
Read moreLONDON (Alliance News) - Syncona Ltd on Tuesday said it was encouraged by portfolio firm Blue Earth Diagnostics prostate cancer imaging tests results.The healthcare company said that a on a
Read more
Last checked at